Pure Biologics S.A. (WSE:PUR)
Poland · Delayed Price · Currency is PLN 6.61
-0.04 (-0.53%)
Aug 14, 2025, 5:04 PM CET
Pure Biologics Market Cap
Pure Biologics has a market cap or net worth of 26.96 million as of August 14, 2025. Its market cap has decreased by -72.11% in one year.
Market Cap
26.96M
Enterprise Value
41.15M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
6.61
Market Cap Chart
Since December 11, 2018, Pure Biologics's market cap has increased from 26.85M to 26.96M, an increase of 0.41%. That is a compound annual growth rate of 0.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 27.10M | -57.96% |
| Dec 30, 2024 | 64.47M | 53.27% |
| Dec 29, 2023 | 42.06M | -18.86% |
| Dec 30, 2022 | 51.84M | -70.44% |
| Dec 30, 2021 | 175.36M | -4.91% |
| Dec 30, 2020 | 184.42M | 226.98% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 6.59B |
| NEUCA | 2.93B |
| Voxel | 1.88B |
| Synektik Spólka Akcyjna | 1.81B |
| Celon Pharma | 1.22B |
| Ryvu Therapeutics | 697.07M |
| Selvita | 607.57M |
| Centrum Medyczne ENEL-MED | 559.95M |